A bag for forming a closed-system spheroid "WELLBAG",
Utilized in the manufacturing process of allogeneic iPS cell-derived islet cell sheets provided for physician-led clinical trials at Kyoto University Hospital.

In the phase 1/1b clinical trial led by physicians at Kyoto University Hospital, evaluating the safety of "OZTx-410" (allogeneic iPS cell-derived islet cell sheets) for type 1 diabetes patients eligible for islet transplantation, the first patient received a transplant of "OZTx-410" provided by Orizuru Therapeutics, Inc.

The manufacturing process of "OZTx-410" utilized our bag for forming a closed-system spheroid, "WELLBAG."